To study antigen cross-presentation mediated by PapMV VLPs, we developed an in vitro assay consisting of a 6-hour pulsing of APC with PapMV VLPs fused to specific MHC-I epitope from influenza M1 or melanoma gp100. This evidence concerns the gene PMEL and melanoma.